Director/PDMR Shareholding

RNS Number : 9381U

GlaxoSmithKline PLC

01 July 2009

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 30 June 2009, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £10.72 per Ordinary share and $35.54 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2009 to 30 June 2009 following this allocation, their total allocations are shown below:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	43,462.43
Prof. Sir Roy Anderson	4,375.53
Dr Stephanie Burns		4,337.90
Mr Lawrence Culp		15,537.94
Sir Crispin Davis	33,257.85
Sir Deryck Maughan		14,339.19
Mr James Murdoch	201.82
Dr Daniel Podolsky		6,847.75
Mr Tom de Swaan	7,052.40
Sir Robert Wilson	8,963.43

The Company and the Non-Executive Directors were informed of these allocations on 1 July 2009.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

1 July 2009

 

END

 

 

RDSZFLFBKDBLBBF